Jiangsu Hanbon Science and Technology Co., Ltd. (SHA:688755)

China · Delayed Price · Currency is CNY

37.61

+0.03 (0.08%)

At close: May 26, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Medical Products	735.13M	690.88M	619.01M	481.79M	320.51M
Medical Products Growth	6.40%	11.61%	28.48%	50.32%	6.03%
Total	735.13M	690.88M	619.01M	481.79M	320.51M
Total Growth	6.40%	11.61%	28.48%	50.32%	6.03%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
China	640.70M	-	530.51M	451.88M	307.20M
China Growth	-	-	17.40%	47.10%	11.80%
Overseas	94.24M	-	87.80M	29.42M	12.88M
Overseas Growth	-	-	198.47%	128.46%	-52.60%
Total	734.93M	-	618.32M	481.30M	320.07M
Total Growth	-	-	28.47%	50.37%	6.01%

Source: S&P Global Market Intelligence.